Finding new medicines to fight CF and ultimately a cure is the driving force behind the Cystic Fibrosis Foundation. To achieve this goal, we aggressively invest in drug development research with the most successful and innovative biotech companies and scientists in the world. We're attacking the disease from every angle.
Click on the interactive pipeline below to learn more. You'll see nearly 30 CF drugs in development or already in use by patients — more than in the entire history of the disease. The Foundation is propelling each of these medicines forward and will not stop until there is a cure.
New: Kalydeco™ received approval from the FDA on January 31, 2012 for people with CF ages 6 and older with the G551D mutation of CF.
